Literature DB >> 29776896

Islet transplantation in type 1 diabetes: moving forward.

Shareen Forbes1, Peter A Senior2, A M James Shapiro2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29776896     DOI： 10.1016/S2213-8587(18)30107-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  3 in total

1.  Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetes.

Authors:  Salamah M Alwahsh; Omar Qutachi; Philip J Starkey Lewis; Andrew Bond; June Noble; Paul Burgoyne; Nik Morton; Rod Carter; Janet Mann; Sofia Ferreira-Gonzalez; Marta Alvarez-Paino; Stuart J Forbes; Kevin M Shakesheff; Shareen Forbes
Journal:  Am J Transplant       Date:  2021-02-02       Impact factor: 9.369

2.  Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.

Authors:  Laura J Reid; Fraser W Gibb; Helen Colhoun; Sarah H Wild; Mark W J Strachan; Karen Madill; Baljean Dhillon; Shareen Forbes
Journal:  Diabetologia       Date:  2021-05-08       Impact factor: 10.122

3.  The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program.

Authors:  Shareen Forbes; Anneliese J Flatt; Denise Bennett; Robert Crookston; Mirka Pimkova; Linda Birtles; Andrew Pernet; Ruth C Wood; Keith Burling; Peter Barker; Claire Counter; Alistair Lumb; Pratik Choudhary; Martin K Rutter; Miranda Rosenthal; Andrew Sutherland; John Casey; Paul Johnson; James A M Shaw
Journal:  Am J Transplant       Date:  2021-08-22       Impact factor: 9.369
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.